Jump to top menu Jump to main menu Jump to content

Research

From fundamental science to societal solutions - our research advances knowledge, improves health, and supports people in managing their well-being.

Directly to

Research Facilities
Research Support
Researchers
Departments and Centers
Groups and Labs

Amazing Erasmus MC

Read more articles
  • New mechanism in BRCA2 tumors discovered: why chemotherapy sometimes fails News

    New mechanism in BRCA2 tumors discovered: why chemotherapy sometimes fails

    Why do some BRCA2 tumors eventually stop responding to chemotherapy? Researchers at Erasmus MC discovered how these tumors are still able to repair their DNA damage and how they evade the effects of chemotherapy.

    Read more
  • Nearly €20 Million to Drive Innovation in Imaging Technology News

    Nearly €20 Million to Drive Innovation in Imaging Technology

    A national consortium led by Erasmus MC has been awarded €19.6 million through the NWO Large-Scale Research Infrastructures program. The consortium, known as AMICE (Advanced Multimodal Imaging Centers), will invest over the next decade in advancing and refining imaging technologies that are essential for cutting-edge biomedical research.

    Read more
  • Screening reduces prostate cancer mortality, even after more than twenty years News

    Screening reduces prostate cancer mortality, even after more than twenty years

    A prostate cancer screening program can reduce prostate cancer mortality, even in the long term. That is the take-away from research conducted by Erasmus MC in a large European group of screened men. ‘The longer the follow-up, the more reliable the results.’

    Read more
  • Biomarker may predict Parkinson’s disease progression News

    Biomarker may predict Parkinson’s disease progression

    Researchers at Erasmus MC have discovered a biomarker in the blood that can predict the progression of Parkinson’s disease. ‘Knowing how severe the disease will be in three years allows doctors to plan treatment much more precisely. ’

    Read more
  • New Erasmus MC Subsidiary Develops Personalized Immunotherapy News

    New Erasmus MC Subsidiary Develops Personalized Immunotherapy

    Erasmus MC has established a new company dedicated to developing a new form of immunotherapy. This new therapy — a personalized cancer vaccine — is intended for patients with pancreatic cancer.

    Read more
  • New cause found for von Willebrand disease News

    New cause found for von Willebrand disease

    Scientists at Erasmus MC have discovered that von Willebrand disease, the most common inherited bleeding disorder, is not always caused by a genetic defect in the von Willebrand factor gene. Defects in the mechanisms that control secretion of this hemostatic protein can also cause von Willebrand disease, they show.

    Read more

Focus on Societal Challenges as driver of Research

As a university medical center, Erasmus MC has a great responsibility to help solve social issues related to health. The research strategy 2023-2029 ‘Focus on Societal Challenges as driver op Research’, clarifies the direction we want to take as a scientific organization at the center of society.

The strategy, which is in line with Erasmus MC’s mission and core values, describes how we can increase the impact of our research and strategically deploy the limited resources available for scientific research. And how we, together with our stakeholders, can effectively contribute to solutions, now and in the future.

Read more about our strategy

Amazing Erasmus MC

Research masters

PhD Trajectory